Q2 2020 G1 Therapeutics Inc Earnings Call Transcript
Ladies and gentlemen, thank you for standing by and welcome to the G1 Therapeutics Second Quarter 2020 Fiscal Results Conference Call. (Operator Instructions) I would now like to hand the conference over to your speaker today, Mr. Jeff Macdonald. Thank you. Please go ahead, sir.
Thank you, operator. Good afternoon, everyone, and welcome to the G1 Therapeutics Second Quarter 2020 Corporate Financial Update.
On today's call, Mark Velleca, Chief Executive Officer; Soma Gupta, Chief Commercial Officer; Raj Malik, Chief Medical Officer and Senior Vice President, R&D; and Jen Moses, Chief Financial Officer, will provide an update of the quarter with Q&A to follow.
Before we begin, I would like to remind you, this call will include forward-looking statements based on current expectations. Such statements represent management's judgment as of today and may involve risks and uncertainties that could cause actual results to differ materially from
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |